Protease inhibitors: First generation, second generation and combinations

被引：0
|
作者：
Mellors, JW
机构：
[1] Univ Pittsburgh, HIV AIDS Program, Pittsburgh, PA 15260 USA
[2] Pittsburgh Vet Affairs Med Ctr, Pittsburgh, PA USA
来源：
AIDS | 1998年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
PL71
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [31] eGFR decrease during antiviral C therapy with first generation protease inhibitors: a clinical significance?
    Loustaud-Ratti, Veronique
    Rousseau, Annick
    Carrier, Paul
    Vong, Chanlina
    Chambaraud, Tristan
    Jacques, Jeremie
    Debette-Gratien, Marilyne
    Sautereau, Denis
    Essig, Marie
    LIVER INTERNATIONAL, 2015, 35 (01) : 71 - 78
  • [32] Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine
    Crane, Heidi M.
    Van Rompaey, Stephen E.
    Kitahata, Mari M.
    AIDS PATIENT CARE AND STDS, 2007, 21 (12) : 920 - 929
  • [33] New Frontiers in Kinases: Second Generation Inhibitors
    Laufer, Stefan
    Bajorath, Juergen
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2167 - 2168
  • [34] Second Generation Proteasome Inhibitors in Multiple Myeloma
    Gozzetti, Alessandro
    Papini, Giulia
    Candi, Veronica
    Brambilla, Corrado Zuanelli
    Sirianni, Santina
    Bocchia, Monica
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (07) : 920 - 926
  • [35] Design of second generation phosphodiesterase 5 inhibitors
    Palmer, Michael J.
    Bell, Andrew S.
    Fox, David N. A.
    Brown, David G.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (04) : 405 - 419
  • [36] Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series
    See, Alfred P.
    Zeng, Jing
    Tran, Phuoc T.
    Lim, Michael
    RADIATION ONCOLOGY, 2011, 6
  • [37] Synthesis and structure-activity relationships of second-generation hydroxamate botulinum neurotoxin A protease inhibitors
    Capkova, Katerina
    Yoneda, Yoshiyuki
    Dickerson, Tobin J.
    Janda, Kim D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (23) : 6463 - 6466
  • [38] MEDI 462-Novel potent second generation HCV NS3 protease inhibitors
    Chen, Kevin X.
    Vibulbhan, Bancha
    Yang, Weiying
    Arasappan, Ashok
    Bennett, Frank
    Blackman, Melissa
    Bogen, Stephane L.
    Huang, Yuhua
    Nair, Latha
    Njoroge, F. George
    Padilla, Angela
    Pan, Weidong
    Pinto, Patrick
    Sannigrahi, Mousumi
    Velazquez, Francisco
    Venkatraman, Srikanth
    Tong, Xiao
    Cheng, Kuo-Chi
    Shih, Neng-Yang
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [39] Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series
    Alfred P See
    Jing Zeng
    Phuoc T Tran
    Michael Lim
    Radiation Oncology, 6
  • [40] New first and second generation inhibitors of human immunodeficiency virus-1 integrase
    Pendri, Annapurna
    Meanwell, Nicholas A.
    Peese, Kevin M.
    Walker, Michael A.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (08) : 1173 - 1189
12345